UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)March 31, 2021
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
(Exact name of registrant as specified in its charter)
|
|
|
|
|
(State or Other Jurisdiction
of Incorporation)
|
(Commission
File Number)
|
(I.R.S. Employer
Identification No.)
|
(Address of Principal Executive Office) (Zip Code)
(561 ) 998-2232
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol | Name of each exchange on which registered |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405) or Rule 12b-2 of the Securities
Exchange Act of 1934 (§240.12b-2).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
|
Item 5.02
|
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers;
Compensatory Arrangements of Certain Officers.
|
On March 31, 2021, Cross
Country Healthcare, Inc. (the “Company”) announced that Stephen A. Saville, Group President, Locums, Education and Corporate Development for the Company, will depart the Company effective April 30, 2021 (the “Effective Date”). The Company
anticipates that Mr. Saville will enter into a severance agreement with the Company as of the Effective Date that will provide benefits consistent with the terms of his previously-disclosed offer letter, which consist of (i) any unpaid base salary through the Effective Date; (ii) reimbursement for unreimbursed business expenses incurred through the Effective Date; (iii) payment of unused vacation
and sick time in accordance with the Company’s policy; and (iv) continued payments of his base salary as in effect at the Effective Date in accordance with the Company’s regular payroll practices for a period of twelve months following the
Effective Date. For a period of one year following the Effective Date, Mr. Saville may not compete with the Company in any jurisdiction in which the Company’s
business is conducted nor may he intentionally interfere with the Company’s relationship with any of its suppliers, customers or employees.
Following the Effective Date, the Company also expects to enter into a consulting agreement with Mr. Saville, pursuant to which Mr.
Saville will provide certain consulting services to the Company as requested by the Company from time to time through May 31, 2021, in exchange for which he will be entitled to certain consulting fees at a rate of $100 per hour and other
benefits.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
| Exhibit |
|
Description |
|
|
|
|
| 104.1 |
|
Cover Page Interactive Data File (embedded within the Inline XBRL document) |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the
undersigned, hereunto duly authorized.
|
|
|
CROSS COUNTRY HEALTHCARE, INC.
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
Dated:
|
March 31, 2021
|
By:
|
/s/ William J. Burns
|
|
|
|
|
|
William J. Burns
|
|
|
|
|
|
Executive Vice President and Chief Financial Officer
|
|